US Stock MarketDetailed Quotes

FBLG FibroBiologics

Watchlist
  • 2.360
  • +0.050+2.16%
Close Dec 27 16:00 ET
  • 2.400
  • +0.040+1.69%
Post 20:01 ET
81.80MMarket Cap-4.50P/E (TTM)

FibroBiologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-128.80%-2.61M
-19.82%-1.95M
-109.97%-4.28M
-57.43%-6.4M
-36.49%-1.6M
16.68%-1.14M
-1.63M
-2.04M
-188.37%-4.07M
-1.17M
Net income from continuing operations
77.19%-500K
141.55%898K
-250.31%-8.46M
-221.91%-16.49M
-537.60%-9.72M
-40.33%-2.19M
---2.16M
---2.42M
-223.70%-5.12M
---1.52M
Operating gains losses
---2.78M
-7,163.16%-4.03M
20,593.33%3.1M
--7.31M
--7.24M
--0
--57K
--15K
----
----
Depreciation and amortization
27.68%143K
41.41%140K
42.71%137K
364.89%437K
38.30%130K
--112K
--99K
--96K
--94K
--94K
Other non cash items
----
----
----
-79.18%81K
--0
--0
--3K
--78K
--389K
--135K
Change In working capital
-108.73%-44K
752.11%463K
262.40%419K
60.59%493K
253.33%318K
8,500.00%504K
---71K
---258K
78.49%307K
--90K
-Change in receivables
----
----
--0
----
----
----
----
---275K
----
----
-Change in prepaid assets
302.44%165K
1,300.00%228K
-3,450.00%-710K
-187.50%-7K
-131.03%-9K
170.69%41K
---19K
---20K
121.62%8K
--29K
-Change in payables and accrued expense
-129.48%-107K
1,556.52%335K
523.86%1.23M
54.67%812K
3.77%275K
390.54%363K
---23K
--197K
125.32%525K
--265K
-Change in other current assets
--0
--0
97.18%-2K
333.33%14K
556.25%105K
977.27%193K
---213K
---71K
75.00%-6K
--16K
-Change in other current liabilities
-9.68%-102K
-9.89%-100K
-10.11%-98K
-48.18%-326K
75.91%-53K
---93K
---91K
---89K
---220K
---220K
Cash from discontinued investing activities
Operating cash flow
-128.80%-2.61M
-19.82%-1.95M
-109.97%-4.28M
-57.43%-6.4M
-36.49%-1.6M
16.68%-1.14M
---1.63M
---2.04M
-188.37%-4.07M
---1.17M
Investing cash flow
Cash flow from continuing investing activities
97.34%-11K
-175.00%-66K
85.71%-8K
-495K
-2K
-413K
-24K
-56K
0
0
Net PPE purchase and sale
97.34%-11K
-175.00%-66K
85.71%-8K
---495K
---2K
---413K
---24K
---56K
--0
--0
Cash from discontinued investing activities
Investing cash flow
97.34%-11K
-175.00%-66K
85.71%-8K
---495K
---2K
---413K
---24K
---56K
--0
--0
Financing cash flow
Cash flow from continuing financing activities
375.64%4.47M
89.96%-172K
-77.50%3.28M
132.79%13.79M
0
413.33%940K
-1.71M
14.57M
226.09%5.93M
2.15M
Net issuance payments of debt
---172K
-157.33%-172K
--459K
-92.05%300K
--0
--0
--300K
--0
147.54%3.78M
--0
Net common stock issuance
--4.64M
--0
--2.82M
----
----
--0
--0
--0
----
----
Net preferred stock issuance
--0
--0
--0
650.60%16.14M
--0
--940K
--10.31M
--4.89M
--2.15M
--2.15M
Proceeds from stock option exercised by employees
----
----
--0
----
----
----
----
--10M
----
----
Net other financing activities
----
----
----
---2.65M
--0
--0
---2.32M
---323K
----
----
Cash from discontinued financing activities
Financing cash flow
375.64%4.47M
89.96%-172K
-77.50%3.28M
132.79%13.79M
--0
413.33%940K
---1.71M
--14.57M
226.09%5.93M
--2.15M
Net cash flow
Beginning cash position
-47.50%5.97M
-44.65%8.16M
304.37%9.16M
456.76%2.27M
735.22%10.77M
284.91%11.38M
--14.74M
--2.27M
--407K
--1.29M
Current changes in cash
402.94%1.85M
35.01%-2.19M
-108.06%-1.01M
271.01%6.9M
-264.07%-1.6M
63.29%-612K
---3.36M
--12.47M
356.76%1.86M
--977K
End cash Position
-27.30%7.83M
-47.50%5.97M
-44.65%8.16M
304.37%9.16M
304.37%9.16M
735.22%10.77M
--11.38M
--14.74M
456.76%2.27M
--2.27M
Free cash flow
-68.62%-2.62M
-22.07%-2.01M
-104.73%-4.28M
-69.60%-6.9M
-36.66%-1.6M
-13.53%-1.55M
---1.65M
---2.09M
-188.37%-4.07M
---1.17M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -128.80%-2.61M-19.82%-1.95M-109.97%-4.28M-57.43%-6.4M-36.49%-1.6M16.68%-1.14M-1.63M-2.04M-188.37%-4.07M-1.17M
Net income from continuing operations 77.19%-500K141.55%898K-250.31%-8.46M-221.91%-16.49M-537.60%-9.72M-40.33%-2.19M---2.16M---2.42M-223.70%-5.12M---1.52M
Operating gains losses ---2.78M-7,163.16%-4.03M20,593.33%3.1M--7.31M--7.24M--0--57K--15K--------
Depreciation and amortization 27.68%143K41.41%140K42.71%137K364.89%437K38.30%130K--112K--99K--96K--94K--94K
Other non cash items -------------79.18%81K--0--0--3K--78K--389K--135K
Change In working capital -108.73%-44K752.11%463K262.40%419K60.59%493K253.33%318K8,500.00%504K---71K---258K78.49%307K--90K
-Change in receivables ----------0-------------------275K--------
-Change in prepaid assets 302.44%165K1,300.00%228K-3,450.00%-710K-187.50%-7K-131.03%-9K170.69%41K---19K---20K121.62%8K--29K
-Change in payables and accrued expense -129.48%-107K1,556.52%335K523.86%1.23M54.67%812K3.77%275K390.54%363K---23K--197K125.32%525K--265K
-Change in other current assets --0--097.18%-2K333.33%14K556.25%105K977.27%193K---213K---71K75.00%-6K--16K
-Change in other current liabilities -9.68%-102K-9.89%-100K-10.11%-98K-48.18%-326K75.91%-53K---93K---91K---89K---220K---220K
Cash from discontinued investing activities
Operating cash flow -128.80%-2.61M-19.82%-1.95M-109.97%-4.28M-57.43%-6.4M-36.49%-1.6M16.68%-1.14M---1.63M---2.04M-188.37%-4.07M---1.17M
Investing cash flow
Cash flow from continuing investing activities 97.34%-11K-175.00%-66K85.71%-8K-495K-2K-413K-24K-56K00
Net PPE purchase and sale 97.34%-11K-175.00%-66K85.71%-8K---495K---2K---413K---24K---56K--0--0
Cash from discontinued investing activities
Investing cash flow 97.34%-11K-175.00%-66K85.71%-8K---495K---2K---413K---24K---56K--0--0
Financing cash flow
Cash flow from continuing financing activities 375.64%4.47M89.96%-172K-77.50%3.28M132.79%13.79M0413.33%940K-1.71M14.57M226.09%5.93M2.15M
Net issuance payments of debt ---172K-157.33%-172K--459K-92.05%300K--0--0--300K--0147.54%3.78M--0
Net common stock issuance --4.64M--0--2.82M----------0--0--0--------
Net preferred stock issuance --0--0--0650.60%16.14M--0--940K--10.31M--4.89M--2.15M--2.15M
Proceeds from stock option exercised by employees ----------0------------------10M--------
Net other financing activities ---------------2.65M--0--0---2.32M---323K--------
Cash from discontinued financing activities
Financing cash flow 375.64%4.47M89.96%-172K-77.50%3.28M132.79%13.79M--0413.33%940K---1.71M--14.57M226.09%5.93M--2.15M
Net cash flow
Beginning cash position -47.50%5.97M-44.65%8.16M304.37%9.16M456.76%2.27M735.22%10.77M284.91%11.38M--14.74M--2.27M--407K--1.29M
Current changes in cash 402.94%1.85M35.01%-2.19M-108.06%-1.01M271.01%6.9M-264.07%-1.6M63.29%-612K---3.36M--12.47M356.76%1.86M--977K
End cash Position -27.30%7.83M-47.50%5.97M-44.65%8.16M304.37%9.16M304.37%9.16M735.22%10.77M--11.38M--14.74M456.76%2.27M--2.27M
Free cash flow -68.62%-2.62M-22.07%-2.01M-104.73%-4.28M-69.60%-6.9M-36.66%-1.6M-13.53%-1.55M---1.65M---2.09M-188.37%-4.07M---1.17M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
+0.58%
Halozyme Therapeutics
HALO
+0.21%
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
0.00%
YETI Holdings
YETI
-0.08%
Dorian LPG
LPG
-0.25%

Unlock the Full List